Introduction
============

Life style-related pathologic conditions, such as obesity, diabetes mellitus, hypertension and hyperlipidemia, are causatively associated with oxidative stress \[[@B1]\]. Thus, consuming antioxidative food in the daily life may decrease the burden of oxidative stress and may be beneficial for the promotion of health \[[@B2]\]. Recently, many kinds of functional foods claiming their supportive role are already in the market. However, only small fraction of those has been evaluated with established methods. It would be useful to provide evidence that antioxidative food is really functional with a scientific approach.

Among the functional foods, black soybeans are one of the most popular beans in Japan. Black soybean contains higher levels of anthocyanins than regular soybean \[[@B3]\]. Anthocyanins are water-soluble pigments that are found in many plants, including black soybean. Dietary intake of anthocyanins is estimated to be 180 to 225 mg/day in the United States \[[@B4]\], and has an antioxidant effect and prescribed as medicine in many countries \[[@B5]\]. The major anthocyanin in black soybean is cyanidin-3-*O*-β-glucoside (C3G). C3G shows well-known red color below pH 4, when it forms most stable flavylium cation \[[@B6]\]. C3G is reactive towards reactive oxygen species (ROS) since its structure is able to donate electrons or transfer hydrogen atoms from hydroxyl moieties to free radicals \[[@B7]\].

Traditional fermented foods have been recognized as healthy food, and attracted much attention because they are related to longevity in Japan \[[@B8]\]. During fermentation, ingredients may be converted to well-balanced forms, which are beneficial for animals \[[@B9]\]. Thus, we may expect synergistic effect of antioxidative potential in the combination of anthocyanins and fermentation. We focused on citric acid fermentation beverage of black soybean (BBS) and investigated its antioxidative effect. BBS also contains other antioxidants that are yet to be elucidated.

To study the antioxidative effect of BBS *in vivo*, we used an animal model of oxidative renal tubular damage induced by ferric nitrilotriacetate (Fe-NTA) \[[@B10]\]. Nitrilotriacetate (NTA) is an aminotricarboxylic acid that efficiently forms water-soluble chelate complexes with many metal cations at neutral pH \[[@B11]\]. This iron chelate catalyzes the generation of ROS and accelerates lipid peroxidation in the kidney through the intraperitoneal (i.p.) administration in rats and mice \[[@B12], [@B13]\]. Repeated i.p. administration of Fe-NTA produces acute and sub-acute renal proximal tubular oxidative damage and remodeling of tubular structure that finally lead to a high incidence of renal cell carcinoma \[[@B14]--[@B16]\]. At the acute phase, oxidatively modified molecules are increased in the kidney after Fe-NTA treatment. For example, an increase in malondialdehyde \[[@B17]\], thiobarbituric acid-reactive substances (TBARS), oxidized glutathione \[[@B18]\], 4-hydroxy-2-nonenal (HNE)-modified proteins \[[@B19]--[@B21]\], 8-hydroxy-2\'-deoxyguanosine (8-OHdG) \[[@B22], [@B23]\] and prostaglandin F~2α~ \[[@B24]\] was shown. Regarding genetic alternations of this carcinogenetic model, homogygous deletion of *p16*^INK4A^ tumor suppressor gene that is an inhibitor of cyclin-dependent kinase was a frequent observation \[[@B25]\] with its monoallelic loss occurring as early as 3 weeks after the start of the protocol \[[@B26]\]. The other target genes in carcinogenesis and progression include *annexin2* \[[@B27]\], *ptprz1* \[[@B28]\] and *aminoacylase1* \[[@B29]\]. Although the potent action of hepatic tumor promotion was also reported \[[@B30]\], Fe-NTA administration alone does not induce primary hepatic tumor.

Well-known antioxidants such as Vitamin E \[[@B31]\], curcumin \[[@B32]\], probucol \[[@B33]\], lycopene \[[@B34]\], nordihydroguairetic acid, garlic oil \[[@B35]\], propolis (artepillin C) \[[@B36]\] and colored rice \[[@B37]\] have been reported to show protective effect in this carcinogenesis model. Based on these studies, this experimental model is useful for the evaluation of antioxidants *in vivo*. In the present study, we show for the first time that beverage containing fermented black soybean has advantageous effects on oxidative stress-induced renal injury *in vivo*. Possible mechanisms and its implication will be discussed.

Materials and Methods
=====================

Chemicals
---------

Iron nitrate enneahydrate, nitrilotriacetic acid, oxidized and reduced glutathione, glutathione reductase, hydrogen peroxide were purchased from Wako (Osaka, Japan). Nicotinamide adenine dinucleotide phosphate reduced, glucose-6-phosphate, 1-chloro-2,4-dinitrobenzene (CDNB), 2,6-dichloroindophenol sodium salt hydrate (DCIP), 5,5\'-dithio-*bis*-2-nitrobenzoic acid (DTNB), bovine serum albumin, trichloroacetic acid, tween 20 were from Sigma (St. Louis, MO). 2-Thiobarbituric acid was from Merck (Darmstadt, Germany). BCA assay kit was from Pierce (Rockford, IL). Citric acid fermentation beverage of black soybean (BBS; Gokoku-maroyaka-su) was a kind gift from Kimise Shoyu (Okayama, Japan). Normal goat serum was from Vector Laboratories (Burlingame, CA) and Histofine Simple Stain rat Max-PO (multi) was from Nichirei (Tokyo, Japan). Liquid 3-3\'-diaminobenzidine (DAB) was from DAKO Cytomation (Kyoto, Japan). Two monoclonal antibodies against 8-OHdG (N45.1) \[[@B23]\] and HNE-modified proteins (HNE-J2) \[[@B38]\] were from Japan Institute for the Control of Aging (Shizuoka, Japan). All the other chemicals were of the highest quality available from Wako (Osaka, Japan).

Determination of nutrients, trace metals and C3G in BBS
-------------------------------------------------------

Diet composition and trace metals were analyzed according to the standard procedure. Anthocyanidin was measured using HPLC by the method of Miyazawa *et al.* \[[@B39]\].

Preparation of Fe-NTA solution
------------------------------

The Fe-NTA solution was prepared by the method of Awai *et al.* \[[@B40]\]. In brief, nitrilotriacetic acid (NTA) and iron nitrate enneahydrate were dissolved in distilled water. The pH was adjusted to 7.0 with sodium bicarbonate. The molar ratio Fe to NTA was 1:4.

Animal experiments
------------------

The Animal Care Committee of Okayama University Graduate School of Medicine and Dentistry approved this experiment. Care and handling of the animals were in accordance with National Institutes of Health Guidelines. Male Wistar rats (7 week-old) were purchased from Japan SLC (Hamamatsu, Japan). They were housed in a temperature-controlled (25°C with alternating 12 h light/12 h dark cycles), and were allowed free access to distilled water and standard chow diet (MF; Oriental Yeast, Tokyo, Japan) during experiment. They were used for experiments after passing one week of acclimatization.

A total of 42 rats (190--210 g) were used for the following experiments. Each animal received 10 ml/kg of BBS using gastric tube, 30 min prior to the i.p. injection of 9.0 mg iron/kg body weight Fe-NTA. In a preliminary study, we prepared condensed BBS and performed a dose-dependence study, which determined the administration of BBS containing 130 µg/kg body weight of cyanidin (refer to Table [1](#T1){ref-type="table"}) as the most effective dose for Fe-NTA-induced renal tubular damage. After sacrifice, the kidneys were immediately removed for enzyme assays and histological examination.

Determination of TBA-reactive substances
----------------------------------------

Lipid peroxidation was measured via production of TBARS by the method of Hamazaki *et al.* \[[@B10]\] with slight modification described by Iqbal *et al.* \[[@B41]\].

Determination of creatinine and blood urea nitrogen (BUN)
---------------------------------------------------------

Blood urea nitrogen and creatinine in sera were measured by auto-analyzer (Hitachi 7600-110S).

Determination of renal antioxidant enzyme activities
----------------------------------------------------

These enzymatic activities were assayed by post-mitochondrial supernatant of renal homogenate. Glutathione peroxidase activity was measured by the method of nicotinamide adenine dinucleotide phosphate, reduced (NADPH) oxidation in a coupled system \[[@B42]\]. Glutathione reductase activity was measured by the method of NADPH oxidation \[[@B43]\]. Glutathione *S*-transferase activity toward CDNB as a substrate was measured by the method of Habig *et al.* \[[@B44]\]. Glucose-6-phosphate dehydrogenase activity was measured by the method of NADPH formation \[[@B45]\]. Catalase activity was measured by the method of H~2~O~2~ degradation \[[@B46]\]. Quinone reductase activity was measured by the method of Benson *et al.* \[[@B47]\]. Reduced glutathione toward DTNB as a substrate was measured by the method of Mohandas *et al.* \[[@B42]\].

Determination of NADPH
----------------------

NADPH was measured by the method of Zhang *et al.* \[[@B48]\].

Hematoxylin and eosin (HE) staining
-----------------------------------

Kidneys were transversely cut including renal pelvis at 5 mm thickness, and immediately fixed with 10% phosphate-buffered formalin. The samples were fixed overnight, and subjected to paraffin embedding. The paraffin-embedded tissues were cut at 4 µm and mounted on glass slides. These slides were used for hematoxylin and eosin staining and immunohistochemical analyses.

Immunohistochemical analysis
----------------------------

Immunohistochemical analyses were performed as previously described \[[@B23], [@B49]\]. Immunostainings were quantified using NIH image 1.63 as described \[[@B23]\].

Statistical analysis
--------------------

Statistical analyses were performed with one-way analysis of variance (ANOVA) and an unpaired *t* test. The difference was considered significance when *p*\<0.05. In animal studies, data are presented as means ± standard deviation (*N* = 6--7) unless otherwise specified.

Results
=======

Nutrients, trace metals and anthocyanidins in BBS
-------------------------------------------------

Nutrients and levels of trace metals and anthocyanidins in the BBS are summarized in Table [1](#T1){ref-type="table"}. Only cyanidin was detectable among 6 forms of anthocyanidins. The levels of ascorbic acid and α-tocopherol were below the detection limit.

TBARS
-----

TBARS was elevated 1 h after Fe-NTA treatment in comparison with untreated animals. This elevation was significantly suppressed by BBS pretreatment (Fig. [1](#F1){ref-type="fig"}).

Serum creatinine and BUN
------------------------

Four and 24 h after Fe-NTA administration, an elevation of creatinine and BUN in sera was evident. Pretreatment with BBS suppressed the elevations of these parameters at both time points. Essentially the same effect was observed by the data of creatinine and BUN (Fig. [2](#F2){ref-type="fig"} A--D).

Antioxidative enzyme activity
-----------------------------

Activities of all the antioxidative enzymes were decreased 4 h after Fe-NTA treatment, and BBS pretreatment prevented this decrease (Fig. [3](#F3){ref-type="fig"}). The same tendency was observed in many of the representative enzymes 24 h after Fe-NTA treatment (Fig. [4](#F4){ref-type="fig"}).

Determination of Reduced Glutathione (GSH) and NADPH
----------------------------------------------------

Renal reduced GSH showed remarkable depletion 1 h after Fe-NTA administration with or without BBS pretreatment (Untreated 6.90 ± 0.71; Fe-NTA-1h, ^\#\#\#^1.99 ± 0.20; BBS + Fe-NTA-1h, ^\#\#\#^2.02 ± 0.37; mmol/g tissue, *N* = 6--7, means ± SEM; ANOVA, *p*\<0.0001, ^\#\#\#^*p*\<0.001 vs untreated). At 4 h, BBS pretreatment did not show protective effects against oxidative stress. However at 24 h, BBS pretreatment restored GSH level faster than Fe-NTA alone group (Fe-NTA-4h, ^\#\#^3.69 ± 0.27, BBS + Fe-NTA-4h, ^\#\#^3.63 ± 1.25; Fe-NTA-24h, ^\#\#^3.99 ± 0.12; BBS + Fe-NTA-24h, \*5.33 ± 0.20; mmol/g tissue, *N* = 6--7, means ± SEM; ANOVA, *p* = 0.017 and *p* = 0.0005 for 4 h and 24 h, respectively; \**p*\<0.05 vs FeNTA alone, ^\#\#^*p*\<0.01 vs untreated). NADPH showed the same tendency as GSH (Untreated 10.24 ± 0.71; Fe-NTA-1h, ^\#\#^4.54 ± 0.37; BBS + Fe-NTA-1h, ^\#\#^4.95 ± 0.55; Fe-NTA-4h, ^\#\#^5.03 ± 0.56; BBS + Fe-NTA-4h, ^\#\#^5.12 ± 0.51, Fe-NTA-24h, ^\#\#\#^3.75 ± 0.43; BBS + Fe-NTA-24h, ^\#\#^4.82 ± 0.62; µmol/g tissue, *N* = 6--7, means ± SEM; ANOVA, *p*\<0.0001, *p*\<0.0001 and *p*\<0.0001 for 1 h, 4 h and 24 h, respectively; ^\#\#^*p*\<0.01 and ^\#\#\#^*p*\<0.001 vs untreated).

Histology
---------

Representative renal histology of Fe-NTA-treated rats 4 h after Fe-NTA treatment is shown (Fig. [5](#F5){ref-type="fig"}B). Acute tubular necrosis was apparent in the proximal tubules. Pretreated rats with BBS 30 min before Fe-NTA administration were highly protected from tubular injury (Fig. [5](#F5){ref-type="fig"}C).

In the cases of Fe-NTA-treated rats, degenerative proximal tubular cells revealing HNE-modified proteins were observed. However, the number of HNE-positive tubules was significantly decreased in the BBS-treated group. No positive tubules with apparent HNE-modified proteins were observed in the untreated group (Fig. [5](#F5){ref-type="fig"} D--F).

Increased 8-OHdG positive cells were observed in Fe-NTA-treated groups. However, BBS-pretreated group revealed suppression in the number of 8-OHdG positive renal tubular cells in each rat. This protective effect was statistically significant (Fig. [6](#F6){ref-type="fig"}).

Discussion
==========

BBS aimed to make the best of antioxidant effect of anthocyanins. The analysis of digested ingredients demonstrated that cyanidin was the major source among 6 forms of anthocyanidins, and ascorbic acid and α-tocopherol were under detection limit. These results suggest that major antioxidants in BBS were cyanidin and its glycosylated derivatives. The distribution of C3G in kidney is reported to be the maximum 30 to 45 min after oral administration in animals \[[@B39], [@B50], [@B51]\]. We adopted this protocol after preliminary experiments.

Prior oral BBS administration to animals that were subjected to Fe-NTA treatment significantly reduced the formation of TBARS and 8-OHdG in the kidney. Serum markers for renal dysfunction showed a marked decrease with BBS pretreatment. Activities of renal antioxidative enzymes were well preserved after Fe-NTA treatment in the BBS pretreated rats. Thus, BBS played a role in scavenging radicals and protected tissue from oxidative damage. Our study for the first time demonstrated that extracts containing fermentated black soybean have a protective effect on iron-catalyzed oxidative tissue injury.

There are four possible explanations for the antioxidative effects of anthocyanins; namely, direct and indirect antioxidative effects, effects on iron absorption/transportation, and nutritional factor. In our preliminary experiments, the antioxidative effect of BBS was not proportionally dose-dependent. We found that most effective dosage of BBS as oral administration was 10 ml/kg containing 130 µg/kg of cyanidin. This may be due to saturation effect under pharmacokinetic characteristics of cyanidin and other components. We speculate that the present effect of BBS was synergistic with other BBS ingredients because the dosage of cyanidin was very low compared with the dosage previously reported \[[@B37]\]. This synergistic antioxidative effect to modulate the above mentioned four possible mechanisms may have been partially induced by fermentation as reported for black soybean \[[@B52]\] and green tea \[[@B9]\]. Fermentation of black soybean enhanced not only the contents of aglycon and vitamin K~2~ but also the superoxide dismutase-like activity \[[@B52]\], thus altering the ingredients to well-balanced functional forms for animals.

Our results demonstrated the functional role of BBS *in vivo*. However, we have to be careful about the general use of BBS since the present study was focused on the iron-catalyzed oxidative renal tubular injury in rats. To investigate the functional role in humans, we also performed epidemiological studies with the approval of Human Investigation Ethics Committee of Okayama University Graduate School of Medicine and Dentistry. We measured antioxidant parameters such as coenzyme Q10 \[[@B53]\], uric acid, polyunsaturated fatty acid, total free fatty acid \[[@B54]\] and urinary excretion of 8-OHdG \[[@B55], [@B56]\]. Only uric acid and monoenoic acid, which are thought as innate antioxidative molecules, showed a trend for increase but within the normal reference value after feeding of 50 ml BBS (Gokoku-maroyaka-su) for 4 weeks by the use of 45 volunteers. BBS may protect its consumption of uric acid and unsaturated fatty acid. There were no significant effects on coenzyme Q10, cholesterol, triacylglycerol, HDL cholesterol, and body weight. During the period of this trial, 6 persons dropped off. Most frequent reason was mild diarrhea. One person complained of allergic dermatitis. After quitting the drink, her redness resolved immediately. There were no persistent complaints and symptoms in all the volunteers. The details will be published elsewhere. Further studies would be necessary to identify which component is important for the antioxidative effect and to clarify the beneficial effects to prevent life style-related diseases.

In conclusion, we for the first time observed that citric acid fermentation beverage of black soybean had a protective effect against Fenton reaction-based renal tubular injury model in rats. Further study is warranted to find human pathologic conditions or genotypes this kind of chemoprevention is most useful.

This work was supported by the grants from Bioactive Okayama.
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![Renal TBA-reactive substances 1 h after intraperitoneal injection of ferric nitrilotriacetate (Fe-NTA). Prior intake of beverage containing fermented black soybean (BBS) decreased TBA-reactive substances. Refer to text for details (ANOVA, *p* = 0.0001; ^\#^*p*\<0.05 vs untreated; \**p*\<0.05 vs Fe-NTA alone).](jcbn10-52f01){#F1}

![Serum markers for renal dysfunction 4 h and 24 h after Fe-NTA administration. (A) Serum creatinine: Fe-NTA 4 h, (B) serum creatinine: Fe-NTA 24 h, (C) serum BUN: Fe-NTA 4 h, (D) serum BUN: Fe-NTA 24 h. Protective effect of BBS was observed (ANOVA, *p*\<0.0001 for A--D; ^\#^*p*\<0.05 vs untreated; \**p*\<0.05 and \*\**p*\<0.01 vs Fe-NTA alone).](jcbn10-52f02){#F2}

![Activities of renal antioxidative enzymes 4 h after Fe-NTA administration. (A) Catalase, (B) GSH peroxidase, (C) GSH reductase, (D) Glucose 6-phosphate dehydorgenase, (E) GSH *S*-transferase, (F) quinone reductase. Protective effects of BBS pretreatment on Fe-NTA-induced renal oxidative damage were observed in all the parameters examined (ANOVA, *p* = 0.0004, *p*\<0.0001, *p* = 0.0012, *p*\<0.0014, *p*\<0.0001 and *p* = 0.0009 for A--F, respectively; ^\#^*p*\<0.05 vs untreated; \**p*\<0.05 and \*\*\**p*\<0.001 vs Fe-NTA alone).](jcbn10-52f03){#F3}

![Activities of renal antioxidative enzymes 24 h after Fe-NTA administration. Representative results of antioxidative enzymes are shown. (A) Catalase, (B) GSH Peroxidase, (C) GSH Reductase. Protective effects of BBS pretreatment on Fe-NTA-induced renal oxidative damage were observed (ANOVA, *p*\<0.0001 for A--C; ^\#^*p*\<0.05 vs untreated; \**p*\<0.05 and \*\*\**p*\<0.001 vs Fe-NTA alone).](jcbn10-52f04){#F4}

![Histological and immunohistochemical analyses of kidney 4 h after Fe-NTA administration. Hematoxylin and eosin staining (HE). (A) untreated, (B) Fe-NTA, (C) BBS pretreatment 30 min before Fe-NTA (BBS + Fe-NTA). Representative images are shown. Scattered necrotic tubules are seen in (B). In (C), only a few degenerative tubules were observed. Immunohistichemical staining of 4-hydroxy-2-nonenal-modified proteins (HNE). (D) untreated, (E) Fe-NTA, (F) BBS + Fe-NTA. HNE immunostaining revealed accumulation of oxidatively modified proteins. Whereas no positive tubule in the HNE immunostaining was observed in (D), many tubules revealed positivity in (E). Immunopositivities were significantly decreased in (F) (bar, 50 µm).](jcbn10-52f05){#F5}

![Immunohistochemical evaluation of 8-hydroxy-2\'-deoxyguanosine (8-OHdG) in the kidney 1 h after Fe-NTA administration. Representative images in each group are shown; (A) untreated, (B) Fe-NTA, (C) BBS + Fe-NTA. Fe-NTA treatment induced intense nuclear staining in the proximal tubular cells. 8-OHdG immunostainings were quantified with NIH image 1.63. Significant decrease in the number of positive cells was observed in BBS-pretreated rats (ANOVA, *p* = 0.0001; ^\#^*p*\<0.05 vs untreated; \*\**p*\<0.01 and vs Fe-NTA alone).](jcbn10-52f06){#F6}

###### 

Constituents of citric acid fermentation beverage of black soybean

  --------------------- ------------
  Anthocyanidins        
                        
   Delphinidin          n.d.
   Cyanidin             6.5 µg/ml
   Petunidin            n.d.
   Pelargonidin         n.d.
   Peonidin             n.d.
   Malvidin             n.d.
                        
  Vitamins              
                        
   Ascorbic acid        n.d.
   α-tocopherol         n.d.
                        
  Minerals and metals   
                        
   Phosphorus           384 µg/ml
   Iron                 1.2 µg/ml
   Calcium              30 µg/ml
   Magnesium            105 µg/ml
   Copper               0.2 µg/ml
   Zinc                 0.05 µg/ml
   Manganese            0.04 µg/ml
  --------------------- ------------

n.d.: not detected. Detection limit; ascorbic acid, 10 µg/ml; α-tocopherol, 1 µg/ml; anthocyanidins, 0.1 µg/ml.
